These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125. Simojoki M, Santala M, Risteli J, Risteli L, Kauppila A. Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196 [Abstract] [Full Text] [Related]
10. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Tamakoshi K, Kikkawa F, Shibata K, Tomoda K, Obata NH, Wakahara F, Tokuhashi Y, Ishikawa H, Kawai M, Tomoda Y. Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294 [Abstract] [Full Text] [Related]
16. Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgery. Meier W, Stieber P, Hasholzner U, Gropp M, Fateh-Moghadam A. Anticancer Res; 1997 Jul; 17(4B):2945-7. PubMed ID: 9329571 [Abstract] [Full Text] [Related]
17. [The role of tumor marker CA 125 in the treatment of ovarian cancer]. Porsbjerg CM, Sørensen JB, Lund BA. Ugeskr Laeger; 1998 Feb 09; 160(7):995-1000. PubMed ID: 9477746 [Abstract] [Full Text] [Related]